Plasma protein analysis of patients with different <scp>B</scp>‐cell lymphomas using high‐content antibody microarrays

Abstract

Variations in plasma protein abundance permit discrimination between different patient groups. After validation on a larger study cohort, the findings could have diagnostic as well as differential diagnostic potential. Beside this, methodological aspects were critically evaluated, such as the value of sample pooling for the identification of biomarkers that are useful for a diagnosis on individual patients.